← Aehr Test Systems overview

Aehr Test Systems vs Advanced Micro Fabrication: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Aehr Test Systems (AEHR)

Q3 2026
▲3▼1

Aehr's AI-driven turnaround: record bookings, but valuation and insider selling raise flags

  • Record bookings and backlog Aehr reported record bookings of $60.7 million and a backlog of $100.6 million, supporting fiscal 2027 revenue guidance of $130–150 million, nearly triple last year's level.

    This is the core new positive development that drove the quarter.

  • AI and silicon photonics demand AI processors and silicon photonics now account for 91–95% of revenue, replacing EV silicon carbide dependence, with repeat orders including $6 million from a hyperscale customer.

    Shows the successful shift to a hot new market, a key driver of the turnaround.

  • Earnings beat and profitability outlook Earnings beat estimates, and management expects a return to profitability, signaling improving financial health.

    Confirms the turnaround is translating into better financial results.

  • Valuation and insider selling risks The stock trades at roughly 81 times trailing sales, analysts see over 40% downside, and the CEO sold $5.2 million in shares—about 20% of his trust holdings—while the company still reports net losses.

    Highlights the major counterweight that could pressure the stock despite operational success.

August 2026
▲3▼1

Aehr's AI test orders and record backlog drive growth, but valuation and insider selling raise caution

  • Record backlog and strong fiscal 2027 guidance Aehr guided fiscal 2027 revenue to $130–$150 million, up to 200% growth, after record bookings of $60.7 million pushed backlog to $100.6 million. That backlog already covers 77% of the low end, giving investors confidence in future sales and pushing the stock up.

    This is the core new financial outlook that directly drives investor expectations for future revenue and profit.

  • Diversification into AI and silicon photonics pays off Aehr now gets 95% of revenue outside EV silicon carbide, with AI processors and silicon photonics making up 91% of last quarter's sales. New orders, including a $22 million AI processor order and silicon photonics production orders, show concrete demand and reduce reliance on the EV market.

    It shows the company successfully shifted its business to faster-growing AI markets, which supports higher future revenue.

  • New $6M follow-on order from hyperscale AI customer Aehr won about $6 million in follow-on orders from its lead hyperscale customer for testing next-generation AI processors. The equipment will ship over six months to a Taiwan partner, adding near-term revenue and confirming that demand from big AI chip makers is real and repeating.

    This is a fresh order that directly adds to revenue and validates the company's growth story with a major customer.

  • CEO sells $5.2 million in shares, valuation stretched CEO Gayn Erickson sold $5.2 million of stock, cutting his trust holdings by 20%, while the company still reports a net loss. The stock trades at a very high price-to-sales ratio, and insider selling can signal that even management sees the shares as fully valued, which may weigh on the price.

    It provides a real counterweight: insider selling and high valuation could limit further gains or trigger a pullback.

Latest
▲3▼1

Aehr's AI test orders and record backlog drive growth, but valuation and insider selling raise caution

  • Record backlog and strong fiscal 2027 guidance Aehr guided fiscal 2027 revenue to $130–$150 million, up to 200% growth, after record bookings of $60.7 million pushed backlog to $100.6 million. That backlog already covers 77% of the low end, giving investors confidence in future sales and pushing the stock up.

    This is the core new financial outlook that directly drives investor expectations for future revenue and profit.

  • Diversification into AI and silicon photonics pays off Aehr now gets 95% of revenue outside EV silicon carbide, with AI processors and silicon photonics making up 91% of last quarter's sales. New orders, including a $22 million AI processor order and silicon photonics production orders, show concrete demand and reduce reliance on the EV market.

    It shows the company successfully shifted its business to faster-growing AI markets, which supports higher future revenue.

  • New $6M follow-on order from hyperscale AI customer Aehr won about $6 million in follow-on orders from its lead hyperscale customer for testing next-generation AI processors. The equipment will ship over six months to a Taiwan partner, adding near-term revenue and confirming that demand from big AI chip makers is real and repeating.

    This is a fresh order that directly adds to revenue and validates the company's growth story with a major customer.

  • CEO sells $5.2 million in shares, valuation stretched CEO Gayn Erickson sold $5.2 million of stock, cutting his trust holdings by 20%, while the company still reports a net loss. The stock trades at a very high price-to-sales ratio, and insider selling can signal that even management sees the shares as fully valued, which may weigh on the price.

    It provides a real counterweight: insider selling and high valuation could limit further gains or trigger a pullback.

July 2026
▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

  • Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.

    This is the core new event that explains the stock's surge and future growth outlook.

  • Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.

    It shows the financial health behind the stock move and supports the bullish case.

  • Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.

    It explains the strategic transformation that is driving new orders and investor enthusiasm.

  • Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.

    It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

  • Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.

    This is the core new event that explains the stock's surge and future growth outlook.

  • Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.

    It shows the financial health behind the stock move and supports the bullish case.

  • Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.

    It explains the strategic transformation that is driving new orders and investor enthusiasm.

  • Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.

    It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

Advanced Micro Fabrication Inc (688012.CG)

Q3 2026
▲4

AMEC Q3: Profit Surge, Expansion, and Potential Samsung Deal

  • Profit Surge First-half profit jumped 282–311% year-on-year on ~35% revenue growth, but part of the gain came from selling a Piotech stake rather than core equipment sales.

    This is the main positive financial news for the quarter.

  • Lingang Expansion AMEC announced a 3.5 billion yuan expansion in Lingang, targeting 3 billion yuan in annual sales, signaling confidence in future demand.

    This is a major new investment that could drive future growth.

  • Samsung/SK Hynix Interest Samsung and SK Hynix reportedly tested AMEC etchers for their China plants, potentially opening a large market, though Samsung denied this.

    This is a new potential catalyst that could significantly boost revenue.

  • CXMT Stake Gain AMEC’s stake in CXMT produced a 736 million yuan paper profit, adding to earnings but not from core operations.

    This is a new one-time gain that boosted reported profits.

August 2026
▲4

AMEC profit surges, expands capacity and domestic share

  • First-half profit jumps over 280% AMEC guided to and then reported first-half net profit up roughly 282-311% year on year, with revenue up about 35%. Part of the gain came from selling a stake in Piotech, so not all profit is from core equipment sales.

    Earnings growth is the clearest fundamental driver of the stock's value.

  • 3.5 billion yuan Lingang expansion AMEC will invest 3.5 billion yuan in phase two of its Lingang base, making etching, inspection and deposition tools. Full production is targeted at 3 billion yuan of annual sales, expanding capacity to meet demand.

    This is a concrete, large capital commitment that signals confidence in future orders.

  • Domestic chip tool demand accelerates Chinese fabs are buying more locally made equipment after Western supply restrictions. AMEC's etchers compete with Lam Research, and its share of the China market is rising toward a leading position, with 800 reaction chambers shipped to top overseas logic customers.

    This is the core long-term demand story that supports revenue growth.

  • New investment vehicles and Wuhan unit AMEC joined a 2.1 billion yuan venture fund with Montage and Jinqiao Capital, and set up a Wuhan subsidiary with 50 million yuan registered capital. These moves widen its investment reach and equipment manufacturing footprint.

    Shows AMEC is deploying capital to expand its ecosystem and production capacity.

Latest
▲4

AMEC profit surges, expands capacity and domestic share

  • First-half profit jumps over 280% AMEC guided to and then reported first-half net profit up roughly 282-311% year on year, with revenue up about 35%. Part of the gain came from selling a stake in Piotech, so not all profit is from core equipment sales.

    Earnings growth is the clearest fundamental driver of the stock's value.

  • 3.5 billion yuan Lingang expansion AMEC will invest 3.5 billion yuan in phase two of its Lingang base, making etching, inspection and deposition tools. Full production is targeted at 3 billion yuan of annual sales, expanding capacity to meet demand.

    This is a concrete, large capital commitment that signals confidence in future orders.

  • Domestic chip tool demand accelerates Chinese fabs are buying more locally made equipment after Western supply restrictions. AMEC's etchers compete with Lam Research, and its share of the China market is rising toward a leading position, with 800 reaction chambers shipped to top overseas logic customers.

    This is the core long-term demand story that supports revenue growth.

  • New investment vehicles and Wuhan unit AMEC joined a 2.1 billion yuan venture fund with Montage and Jinqiao Capital, and set up a Wuhan subsidiary with 50 million yuan registered capital. These moves widen its investment reach and equipment manufacturing footprint.

    Shows AMEC is deploying capital to expand its ecosystem and production capacity.

July 2026
▲4

AMEC Profit Surges, Samsung/SK Hynix Test Equipment, CXMT Stake Gains

  • First-half profit jumps 282-311% on strong demand AMEC expects first-half net profit up 282-311% year-on-year, with revenue up 34.89% to 6.69 billion yuan. The company also plans a 3.5 billion yuan expansion of its Lingang base. This shows booming demand for its chipmaking tools and supports a higher stock price.

    Directly answers why the stock is moving: strong earnings growth and capacity expansion signal robust business momentum.

  • Samsung and SK Hynix test AMEC equipment for China plants Samsung and SK Hynix have been testing AMEC's etching equipment for about two years, aiming to use it at their Chinese plants to avoid US export restrictions. Although Samsung denied the report, the potential endorsement from global chip giants could open a large new market for AMEC.

    This is a major new demand driver that could significantly expand AMEC's customer base and revenue.

  • CXMT strategic placement yields paper profit AMEC participated in the strategic placement of CXMT, a domestic DRAM leader, and its stake generated a paper profit of about 736 million yuan on the first trading day. This reflects AMEC's strategic positioning in the chip supply chain and adds to its investment gains.

    Shows a direct financial benefit and strategic alignment that can boost investor sentiment.

  • New regulations protect IC layout designs China published revised regulations for protecting integrated circuit layout designs, effective October 2026. This supports the industry's shift to high-quality development and could benefit domestic equipment makers like AMEC by fostering a more innovative and protected environment.

    Regulatory support for the semiconductor industry can improve the long-term outlook for AMEC.

▲4

AMEC Profit Surges, Samsung/SK Hynix Test Equipment, CXMT Stake Gains

  • First-half profit jumps 282-311% on strong demand AMEC expects first-half net profit up 282-311% year-on-year, with revenue up 34.89% to 6.69 billion yuan. The company also plans a 3.5 billion yuan expansion of its Lingang base. This shows booming demand for its chipmaking tools and supports a higher stock price.

    Directly answers why the stock is moving: strong earnings growth and capacity expansion signal robust business momentum.

  • Samsung and SK Hynix test AMEC equipment for China plants Samsung and SK Hynix have been testing AMEC's etching equipment for about two years, aiming to use it at their Chinese plants to avoid US export restrictions. Although Samsung denied the report, the potential endorsement from global chip giants could open a large new market for AMEC.

    This is a major new demand driver that could significantly expand AMEC's customer base and revenue.

  • CXMT strategic placement yields paper profit AMEC participated in the strategic placement of CXMT, a domestic DRAM leader, and its stake generated a paper profit of about 736 million yuan on the first trading day. This reflects AMEC's strategic positioning in the chip supply chain and adds to its investment gains.

    Shows a direct financial benefit and strategic alignment that can boost investor sentiment.

  • New regulations protect IC layout designs China published revised regulations for protecting integrated circuit layout designs, effective October 2026. This supports the industry's shift to high-quality development and could benefit domestic equipment makers like AMEC by fostering a more innovative and protected environment.

    Regulatory support for the semiconductor industry can improve the long-term outlook for AMEC.